Drugs@FDA document

SEPTRA Letter · NDA 017376 ORIG-1

Drugs@FDA document · MONARCH PHARMS · Jul 20, 2020

Key facts

Drug name SEPTRA
Document type Letter
Application NDA017376
Submission ORIG-1
Company MONARCH PHARMS
Document date Jul 20, 2020
FDA document accessdata.fda.gov

At a glance

  • 10–99 Documents for this application

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents